BeOne Medicines AG
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $166.5M | $3.33B | $2.63B |
| FY2025 | $961.9M | $4.36B | $4.55B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $166.5M | $3.33B | $2.63B |
| FY2025 | $961.9M | $4.36B | $4.55B |